{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:36:52Z","timestamp":1761824212436,"version":"build-2065373602"},"reference-count":18,"publisher":"Elsevier BV","issue":"31","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.vaccine.2020.05.088","type":"journal-article","created":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T04:09:46Z","timestamp":1591330186000},"page":"4801-4804","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Combine dengue vaccines to optimize effectiveness"],"prefix":"10.1016","volume":"38","author":[{"given":"Alejandro","family":"Macias","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillermo","family":"Ruiz-Palacios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose","family":"Ramos-Castaneda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2020.05.088_b0005","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0140-6736(18)32560-1","article-title":"Dengue","volume":"393","author":"Wilder-Smith","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2020.05.088_b0010","doi-asserted-by":"crossref","first-page":"e0003655","DOI":"10.1371\/journal.pntd.0003655","article-title":"A Critical Assessment of Vector Control for Dengue Prevention","volume":"9","author":"Achee","year":"2015","journal-title":"PLoS NeglTrop Dis"},{"doi-asserted-by":"crossref","unstructured":"Dengue vaccine: WHO position paper, September 2018 - Recommendations. Vaccine 2019;37:4848\u20139.","key":"10.1016\/j.vaccine.2020.05.088_b0015","DOI":"10.1016\/j.vaccine.2018.09.063"},{"key":"10.1016\/j.vaccine.2020.05.088_b0020","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/S0140-6736(20)30414-1","article-title":"Efficacy of a tetravalent dengue vaccine in healthy children aged 4\u201316 years: a randomised, placebo-controlled, phase 3 trial","volume":"395","author":"Biswal","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2020.05.088_b0025","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1056\/NEJMoa1800820","article-title":"Effect of Dengue Serostatus on Dengue Vaccine Safety and Efficacy","volume":"379","author":"Sridhar","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2020.05.088_b0030","doi-asserted-by":"crossref","first-page":"l5710","DOI":"10.1136\/bmj.l5710","article-title":"Is Dengvaxia a useful vaccine for dengue endemic areas?","volume":"367","author":"Gubler","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2020.05.088_b0035","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1038\/s41590-018-0210-3","article-title":"The immune response against flaviviruses","volume":"19","author":"Slon Campos","year":"2018","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2020.05.088_b0040","doi-asserted-by":"crossref","first-page":"14234","DOI":"10.1073\/pnas.0602768103","article-title":"Cross-protective immunity can account for the alternating epidemic pattern of dengue virus serotypes circulating in Bangkok","volume":"103","author":"Adams","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2020.05.088_b0045","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jaut.2017.04.008","article-title":"Original antigenic sin: A comprehensive review","volume":"83","author":"Vatti","year":"2017","journal-title":"J Autoimmun"},{"key":"10.1016\/j.vaccine.2020.05.088_b0050","doi-asserted-by":"crossref","first-page":"e2357","DOI":"10.1371\/journal.pntd.0002357","article-title":"Symptomatic versus inapparent outcome in repeat dengue virus infections is influenced by the time interval between infections and study year","volume":"7","author":"Montoya","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2020.05.088_b0055","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1586\/14760584.2016.1121814","article-title":"Paradoxical role of antibodies in dengue virus infections: considerations for prophylactic vaccine development","volume":"15","author":"Acosta","year":"2016","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2020.05.088_b0060","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/978-981-10-8727-1_17","article-title":"Understanding the Human T Cell Response to Dengue Virus","volume":"1062","author":"Rivino","year":"2018","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.vaccine.2020.05.088_b0065","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1056\/NEJMoa1506223","article-title":"Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease","volume":"373","author":"Hadinegoro","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2020.05.088_b0070","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1093\/infdis\/jiv179","article-title":"Safety and Immunogenicity of a Live Attenuated Tetravalent Dengue Vaccine Candidate in Flavivirus-Naive Adults: A Randomized, Double-Blinded Phase 1 Clinical Trial","volume":"212","author":"George","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2020.05.088_b0075","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1016\/j.vaccine.2011.03.057","article-title":"Live-attenuated, tetravalent dengue vaccine in children, adolescents and adults in a dengue endemic country: randomized controlled phase I trial in the Philippines","volume":"29","author":"Capeding","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.05.088_b0080","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.4269\/ajtmh.14-0145","article-title":"Seroprevalence of neutralizing antibodies against dengue virus in two localities in the state of Morelos","volume":"91","author":"Amaya-Larios","year":"2014","journal-title":"Mexico Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2020.05.088_b0085","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/imr.12648","article-title":"What if protective immunity is antigen-driven and not due to so-called \u201cmemory\u201d B and T cells?","volume":"283","author":"Zinkernagel","year":"2018","journal-title":"Immunol Rev"},{"key":"10.1016\/j.vaccine.2020.05.088_b0090","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/s41586-018-0157-4","article-title":"Reconstruction of antibody dynamics and infection histories to evaluate dengue risk","volume":"557","author":"Salje","year":"2018","journal-title":"Nature"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20307556?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20307556?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:44:19Z","timestamp":1759401859000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20307556"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":18,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S0264410X20307556"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.05.088","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combine dengue vaccines to optimize effectiveness","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.05.088","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}